X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Contemporary Clinical Trials

期刊標題檢索 CONTEMP CLIN TR 最新評論: Do you have any publications now? (2022-03-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Contemporary Clinical Trials]您好,您是該頁面的第 18231 位訪客。

期刊簡介
期刊名稱Contemporary Clinical Trials Contemporary Clinical Trials
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.0

期刊簡稱CONTEMP CLIN TRIALS
ISSN1551-7144
E-ISSN1559-2030
h-index51
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.700.9800.829
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q3138 / 272

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
官方網站http://www.journals.elsevier.com/contemporary-clinical-trials/
在線稿件提交https://www.editorialmanager.com/CCT
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2005
每年文章數242每年文章數趨勢
黃金OA百分比32.59%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3122/189
PHARMACOLOGY & PHARMACYSCIEQ3222/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1551-7144%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
來自Elsevier的數據: Average 5.5 Week(s)
競爭力 *來自作者的數據: Easy
在線文章發布時間來自Elsevier的數據: Average 2.4 Week(s)
參考鏈接
相關期刊 【Contemporary Clinical Trials】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498358
    PHYTOMEDICINE340378
    LIFE SCIENCES285860
    International Journal of Pharmaceutics242451
    PHARMACOLOGICAL RESEARCH241370
    European Journal of Pharmacology204263
    BIOCHEMICAL PHARMACOLOGY202708
    JOURNAL OF NATURAL PRODUCTS196705
    BRITISH JOURNAL OF PHARMACOLOGY165162
    MOLECULAR PHARMACEUTICS162841
  •  

    Contemporary Clinical Trials Contemporary Clinical Trials
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Contemporary Clinical Trials] 的評論撰寫評論
作者: 水桥金钟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-21 17:53:40 評論於
Do you have any publications now?
(0) 讚! | 水桥金钟

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:52:33 評論於
Currently, ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researches related to their publications to use ORCID iD.
If an article is published without providing an ORCID ID, how to add it?
ORCID stands for Open Researcher and Contributor ID. ORCID iD is a unique and persistent academic identity for contributors, distinguishing authors from other researchers and recording all of their relevant research activities. To add an ORCID iD for an author, log in to their account and associate it in the account information settings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:07:14 評論於
Manuscript of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:03:30 評論於
Is it necessary to provide the ORCID IDs of each author when submitting a manuscript?
(0) 讚! | Oswald Edie

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 22:40:29 評論於
What is MS?
(0) 讚! | 魂魄彦露

作者: Kimberley Orlando


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-11 17:11:52 評論於
Could you please let me know if this magazine accepts protocols for meta-analysis?
(0) 讚! | Kimberley Orlando

作者: Kimberley Orlando


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-05 09:48:34 評論於
Does this magazine accept protocols for meta-analysis?
(0) 讚! | Kimberley Orlando

作者: 黑山予曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-05 18:46:40 評論於
Is the review process fast for this?
(0) 讚! | 黑山予曦

作者: 稻妻慧丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-12 17:19:37 評論於
Is this protocol easily transmissible?
(0) 讚! | 稻妻慧丽

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Contemporary Clinical Trials] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*